African Americans are also a group of patients that are over represented in FSGS diagnosis, as are Hispanic children.
You can see why Dimerix are doing this, to show they are racially inclusive & a big lot of trial sites already in Asia & South America, don’t forget all the trial sites in the US as well!
It’s not just China, but of course that is a big deal.
The Big thing for me was the kids included on this presentation. It’s not tugging at heart strings, this will be real following the first interim analysis, FDA Approved, at least with older ones to begin with.
Ann: Investor Presentation, page-35
-
- There are more pages in this discussion • 142 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
-0.005(1.23%) |
Mkt cap ! $222.9M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 43.0¢ | 39.8¢ | $436.4K | 1.067M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 24999 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 11224 | 1 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |